Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
The partners also aim to expand their work to Latin America for the first time
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
Subscribe To Our Newsletter & Stay Updated